About
ProteoMediX develops Proclarix, a protein-based blood test that provides a non-invasive, precise diagnostic support tool for detecting clinically significant prostate cancer and reducing unnecessary biopsies.
Explore ProteoMediX's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.